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Neuro-oncology is a complex field encompassing scientific and clinical developments in the diagno-
sis and management of cancers directly affecting the central nervous system (CNS). These include
brain tumors and metastases, and non-CNS cancers and treatments that produce neurocognitive
impairment. To date, the dominant focus of neuro-oncology literature has been on the biological
mechanisms and neurocognitive effects of brain tumor and cancer. However, neurocognitive
impairments and psychological disorders arise from an interaction between physiological, med-
ical, and psychosocial factors (1). Therefore, to guide holistic models of care, a biopsychosocial
perspective is needed (2).
Psychosocial aspects of care focus on how people perceive and react to their diagnosis and
symptoms and the ways in which they cope with their illness within their social context. Subjective
reports of symptoms are often more closely related to quality of life than objective indices, such as
neuropsychological test performance (2). High rates of depression and anxiety have been consis-
tently reported in neuro-oncology samples, with distress found to persist or even increase over time
(3). Due to the increased emphasis on outpatient care, family members assume the primary role in
supporting individuals to cope with symptoms and the everyday impact of their illness. Cancer can
place strain on relationships and compromise the physical and mental health of family members, in
turn impacting their ability to provide sustained support to the person with cancer (4).
This Research Topic aims to enhance understanding of the neurocognitive and psychosocial
consequences of neuro-oncological disorders. It also aims to showcase advances in supportive care
and highlight future research priorities for this population.
The neurocognitive consequences of cancer were the focus of three articles. A meta-analysis
by Ono and co-authors found overall evidence that adjuvant chemotherapy for breast cancer is
associated with subtle cognitive impairment. To strengthen the evidence base, they recommended
that future prospective longitudinal research examine cognitive impairment levels before and after
chemotherapy, with comparisons made to pre-diagnosis functioning. Robinson and co-authors
posed the question of whether screening tools, such as theMontreal Cognitive Assessment (MoCA),
are sufficiently sensitive to the cognitive effects of brain tumor. Their findings suggested that a brief
but tailored assessment may have greater sensitivity to detect mild or focal effects. Dwan and col-
leagues examined whether rates of cognitive impairment after brain tumor vary according to source
of reference used (i.e., norms, controls, and premorbid functioning). Reassuringly, comparisons
showed that rates of impairment were largely consistent across sources. They advocated for a multi-
faceted neuropsychological test batterywith ameasure of estimated premorbid cognitive functioning
to avoid over- or under-estimation of impairment.
Behavioral and social consequences of brain tumor were the topic of two articles led by Simpson
and Ownsworth. Simpson and co-authors identified that rates of behavioral changes after brain
tumor were variable based on both self-report (7–40%) and relative report (8–60%), and were
higher for people with seizures and poorer functional status. Routine assessment and multi-level
management of behavioral concerns was recommended. Qualitative research by Ownsworth and
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co-authors investigated family caregivers’ experiences of support
and relationship changes. Due to the many issues found to impact
on caregiver perceptions, it was recommended that profession-
als explore caregivers’ expectations and preferences for support
throughout the illness.
Psychological well-being after brain tumorwas the key theme of
two articles. Trad and colleagues used the Distress Thermometer
to screen for distress in different groups of patients and care-
givers at initial diagnosis and tumor recurrence. The high rate of
distress in the patient and caregiver groups at both time points
underscores the key role of neuro-oncology care coordinators
in providing access to psychosocial support throughout the care
continuum. In their perspective article, Ownsworth and Nash
emphasized the importance of assessing existential well-being or
people’s sense ofmeaning, purpose, and value in life, in addition to
mood and distress levels. Different avenues of existential support
were discussed for facilitating the meaning making process across
the illness trajectory.
Supportive care interventions for the neuro-oncology popula-
tion were a focus of five articles, including two intervention stud-
ies. Jones and co-authors piloted a telephone-based psychological
support intervention for people with brain tumor. The results of
their single-case research provided preliminary support for the
feasibility and utility of tele-based therapy for enhancing mental
health and quality of life. A larger controlled trial is needed to
examine factors influencing the efficacy of tele-based therapy.
King and Green evaluated the efficacy of group cognitive reha-
bilitation for cancer survivors in a randomized controlled trial.
Their findings generally supported the efficacy of their group
intervention, with gains most apparent for perceived cognitive
impairment.
In a systematic review of interventions to improve informa-
tion provision for brain tumor patients, Langbecker and Janda
found that most studies reported high rates of satisfaction with
information provision. However, few examined improvements
in knowledge and the methodological quality was generally low.
A scoping review of psychotherapy interventions by Kangas
similarly highlighted the paucity of evidence-based interven-
tions for managing anxiety and depressive symptoms for this
population. Cormie and colleagues considered the potential for
exercise interventions to counteract the broader consequences
of cancer, including fatigue, cognitive impairment, depression,
and anxiety. Their perspective article discusses the benefits of
targeted exercise programs for patients with CNS cancers and
the need for research that examines both safety and efficacy of
interventions.
In the final article of this Research Topic, Chambers and col-
leagues present an overview of the challenges and strategies for
integrating quality standards of psychosocial care into neuro-
oncology. They call for the development of a comprehensive
model of survivorship care for people affected by brain tumor and
their families.
Overall, the development and evaluation of psychological and
supportive care interventions for people with neuro-oncological
illness is an area of emerging research and of high interest to health
professionals working in the field. International quality standards
stipulate the need for cancer care facilities to provide assessments
of patient distress and appropriate interventions (5). This practical
and evidence-based text provides a unique and timely resource
on the psychosocial care needs of people with neuro-oncological
conditions and emerging intervention approaches.
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